Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Axicabtagène ciloleucel et lisocabtagène maraleucel en deuxième ligne chez des patients atteints de lymphome diffus à grandes cellules B (LDGCB) en rechute ou réfractaire : analyse en conditions réelles de pratique du Lymphoma Working Party de l’EBMT

Études rétrospectives

Lymphome non hodgkinien (LNH)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Dr. Anna Ossami SAIDY

Real World Experience of CAR-T in follicular lymphoma: a Lymphoma Working Party-EBMT study

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Dr. Leyre BENTO & Dr. Silvia MONTOTO

Expérience en vie réelle des thérapies CAR-T dans le lymphome folliculaire : étude du Lymphoma Working Party de l’EBMT

Études rétrospectives

Lymphome non hodgkinien (LNH)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Dr. Leyre BENTO & Dr. Silvia MONTOTO

Non-interventional registry-based analysis in the use of Brentuximab Vedotin and/or Checkpoint inhibitors as bridge to autologous stem cell transplantation in Hodgkin lymphoma.

Non-interventional Prospective Studies

Hodgkin’s Disease (HD)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Dr. Ali BAZARBACHI & Dr. Anna SUREDA

Analyse non interventionnelle issue d’un registre portant sur l’utilisation du brentuximab védotine et/ou des inhibiteurs de points de contrôle immunitaire en stratégie de relais vers l’autogreffe de cellules souches hématopoïétiques dans le lymphome de Hodgkin

Études prospectives non interventionnelles

Maladie de Hodgkin (MH)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Dr. Ali BAZARBACHI & Dr. Anna SUREDA

Autologous, Allogeneic Stem-Cell Transplantation and CART Cell therapy for Transformed Waldenström Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL) to High Grade NHL (HGNHL)

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Dr. Charalampia KYRIAKOU & Dr. Nour MOUKALLED

Autogreffe, allogreffe de cellules souches et thérapie par cellules CAR-T dans la macroglobulinémie de Waldenström (MW) / le lymphome lymphoplasmocytaire (LPL) transformés en lymphome non hodgkinien agressif (LNH agressif)

Études rétrospectives

Lymphome non hodgkinien (LNH)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Dr. Charalampia KYRIAKOU & Dr. Nour MOUKALLED

Non-T-Depleted Haploidentical Transplantation Compared to Allogeneic Transplantation From Matched Siblings or Unrelated Donors in Patients With Secondary AML in First Complete Remission: A Study From the ALWP/EBMT

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Acute Leukemia Working Party (ALWP)

Type de traitement

Investigateur principal

Dr. Arnon Nagler

The impact of DNMT3A mutation on survival of AML patients receiving allotransplant in first remission depends on the karyotype and co-occurring mutations

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Acute Leukemia Working Party (ALWP)

Type de traitement

Investigateur principal

Dr. Iman Abou Dalle

Graft-versus-host disease is not associated with reduced incidence of relapse following haploidentical stem cell transplantation with post-transplant cyclophosphamide for acute lymphoblastic leukaemia: A study on behalf of the Acute Leukaemia Working Party of European Society for Blood and Marrow Transplantation

Retrospective Studies

Acute Lymphatic Leukaemia (ALL)

Acute Leukemia Working Party (ALWP)

Type de traitement

Investigateur principal

Dr. Avichai Shimoni

Superior GVHD-Free, Relapse-Free Survival for Haploidentical Transplant With PTCy Than Matched Unrelated Donor for AML Patients Transplanted in Second Complete Remission: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Acute Leukemia Working Party (ALWP)

Type de traitement

Investigateur principal

Older matched sibling donor versus young haplo-identical donor for elderly patients with acute myeloid leukemia

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Acute Leukemia Working Party (ALWP)

Type de traitement

Investigateur principal

Dr. Xavier Poiré